Explore scalable drug delivery device manufacturing at PODD 2026

SHL Advantec will join SHL Medical at PODD 2026 between October 29-30 to explore how our expertise in drug delivery device manufacturing, autoinjector assembly, and medical device automation supports the scalable production of self-injection devices.

As delivery systems advance to accommodate larger volumes and more complex formulations, manufacturing strategies must evolve alongside the device. Changes in device architecture can introduce new requirements for component handling, assembly, testing, process control, and future scale-up. As SHL Medical explores large-volume delivery and the evolving requirements surrounding subcutaneous drug delivery, SHL Advantec will highlight how adaptable drug delivery device manufacturing can support the transition from device development to commercial-scale production.

Together with SHL Medical, SHL Advantec will showcase the proven manufacturing capabilities behind successful device commercialization. Our commercialized SMART and AOU platforms are already contributing to the assembly and final assembly of multiple high-volume autoinjector platforms, including two variants of the Molly 2.25 large-volume autoinjector. By combining this real-world experience with expertise in precision tooling, testing technologies, and medical device automation, we help customers establish reliable and scalable manufacturing processes for drug delivery devices.

Visitors can connect with our team to discuss:

Visitors can meet our team to explore how adaptable manufacturing technologies can support the next generation of large-volume autoinjectors and help drug delivery programs progress toward commercial production.

Where : Sheraton Boston Hotel, Boston, Massachusetts, USA | Booth #112-113

When  : October 29-30, 2026